Logos Global Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,400,000
| Closed | -$20.7M | – | 45 |
|
|
2022
Q4 | $20.7M | Sell |
1,400,000
-125,000
| -8% | -$1.85M | 2.43% | 18 |
|
|
2022
Q3 | $29.1M | Buy |
1,525,000
+525,000
| +53% | +$10M | 3.58% | 10 |
|
|
2022
Q2 | $21.3M | Sell |
1,000,000
-500,000
| -33% | -$10.7M | 3.91% | 11 |
|
|
2022
Q1 | $28.9M | Buy |
1,500,000
+1,250,000
| +500% | +$24.1M | 3.75% | 12 |
|
|
2021
Q4 | $5.19M | Buy |
+250,000
| New | +$5.19M | 0.53% | 40 |
|